The US Food and Drug Administration (FDA) expanded the indications of the Insulet SmartAdjust technology, an interoperable automated glycaemic controller previously indicated for the management of ...
“Since its commercial launch in the United States, Omnipod 5 has had a remarkable impact on people with diabetes,” said Jim Hollingshead, Insulet President and CEO. “Every day, we hear how this ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced ...
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced ...
The FDA has expanded the indications for Insulet SmartAdjust technology to include the management of Type 2 diabetes in people 18 and older. Insulet SmartAdjust is an interoperable, automated glycemic ...
SILVER SPRING, Md., Aug. 26, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration expanded the indications of the Insulet SmartAdjust technology, an interoperable automated glycemic ...
The FDA cleared the first automated insulin dosing device for adults with type 2 diabetes, the agency announced on Monday. An interoperable automated glycemic controller, Insulet's SmartAdjust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results